Ponatinib (AP24534)

Catalog No.S1490

Ponatinib (AP24534) is a novel, potent multi-target inhibitor of Abl, PDGFRα, VEGFR2, FGFR1 and Src with IC50 of 0.37 nM, 1.1 nM, 1.5 nM, 2.2 nM and 5.4 nM in cell-free assays, respectively.

Price Stock Quantity  
USD 100 In stock
USD 110 In stock
USD 370 In stock
USD 970 In stock
Bulk Inquiry

Massive Discount Available

Free Overnight Delivery on all orders over $ 500.

Ponatinib (AP24534) Chemical Structure

Ponatinib (AP24534) Chemical Structure
Molecular Weight: 532.56

Validation & Quality Control

3 customer reviews :

Quality Control & MSDS

Related Compound Libraries

Bcr-Abl Inhibitors with Unique Features

  • Selective Bcr-Abl Inhibitor

    Nilotinib (AMN-107) Bcr-Abl-selective, IC50<30 nM.

  • Most Potent Bcr-Abl Inhibitor

    GZD824 Bcr-Abl(WT), IC50=0.34 nM; Bcr-Abl(T315I), IC50=0.68 nM.

  • FDA-approved Bcr-Abl Inhibitor

    Dasatinib Approved by FDA for CML and Ph+ ALL.

  • Newest Bcr-Abl Inhibitor

    GZD824 Orally bioavailable Bcr-Abl inhibitor for Bcr-Abl(WT) and Bcr-Abl(T315I) with IC50 of 0.34 nM and 0.68 nM, respectively.

Product Information

  • Compare Bcr-Abl Inhibitors
    Compare Bcr-Abl Products
  • Research Area
  • Ponatinib (AP24534) Mechanism

Product Description

Biological Activity

Description Ponatinib (AP24534) is a novel, potent multi-target inhibitor of Abl, PDGFRα, VEGFR2, FGFR1 and Src with IC50 of 0.37 nM, 1.1 nM, 1.5 nM, 2.2 nM and 5.4 nM in cell-free assays, respectively.
Targets Abl [1]
(Cell-free assay)
PDGFRα [1]
(Cell-free assay)
VEGFR2 [1]
(Cell-free assay)
FGFR1 [1]
(Cell-free assay)

 View  More

IC50 0.37 nM 1.1 nM 1.5 nM 2.2 nM
In vitro AP24534 potently inhibits native Abl, AblT315I, and other clinically important Abl kinase domain mutants with IC50 of 0.30 nM–2 nM. AP24534 doesn't inhibit Aurora kinase family members, nor does it inhibit insulin receptor or CDK2/cyclin E. AP24534 inhibits proliferation of Ba/F3 cells expressing Bcr-Abl with IC50 of 0.5 nM, as well as Ba/F3 cells expressing a range of Bcr-Abl mutants with IC50 of 0.5 nM–36 nM. The inhibition of proliferation by AP24534 is correlated with induction of apoptosis. [1-2] In leukemic cell lines containing activated forms of FLT3, KIT, FGFR1, and PDGFRα receptors, AP24534 potently inhibits receptor phosphorylation and cellular proliferation with IC50 of 0.3 nM to 20 nM. In MV4-11 (FLT3-ITD(+/+)) but not RS4;11 (FLT3-ITD(–/–)) AML cells, AP24534 inhibits FLT3 signaling and induced apoptosis at less than 10 nM. AP24534 inhibits viability of primary leukemic blasts from a FLT3-ITD positive AML patient with IC50 of 4 nM but not those from patients with AML expressing native FLT3. [3] In Ba/F3 cells engineered to express activated FGFR1-4, AP24534 potently inhibits FGFR-mediated signaling and viability with IC50 lower than 40 nM. In cell lines representing multiple tumor types (endometrial, bladder, gastric, breast, lung, and colon), and containing FGFRs dysregulated by a variety of mechanisms, AP24534 inhibits FGFR-mediated signaling with IC50 less than 40 nM and inhibits cell growth with IC50 of 7 nM–181 nM. [4]
Cell Data
Cell LinesAssay TypeConcentrationIncubation TimeFormulationActivity DescriptionPMID
EoL-1-cellNUTncI0zT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M4LONmlEPTB;MD6wNFAxODByM{W5JO69VQ>?NWK5No57W0GQR1XS
MV-4-11MV;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MoHXTWM2OD1yLkCwNFA6PTZizszNM{fDUnNCVkeHUh?=
MEG-01NFj3S3VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MnHnTWM2OD1yLkCwNFEzQCEQvF2=M1e3bHNCVkeHUh?=
LAMA-84M4jJSmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M37sVWlEPTB;MD6wNFAyPjVizszNMlHtV2FPT0WU
CGTH-W-1MWPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NGL0NJZKSzVyPUCuNFAyPjlizszNNFzBRmtUSU6JRWK=
KASUMI-1MorGS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NFXyU5BKSzVyPUCuNFAzOTdizszNNI\BfJBUSU6JRWK=
BE-13Ml\HS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NViyW2ViUUN3ME2wMlAxOjV7IN88US=>MYrTRW5ITVJ?
CTV-1M2roSmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M4DNUWlEPTB;MD6wNFUzOSEQvF2=NE\aTXVUSU6JRWK=
NKM-1NVf5W45zT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NYH6[2ZwUUN3ME2wMlAxPjV3IN88US=>NIXkZY9USU6JRWK=
MONO-MAC-6M2WzbWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MUjJR|UxRTBwMEC4N|ch|ryPNWDyOVRiW0GQR1XS
A204MVrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NUOyU5J{UUN3ME2wMlAyOjF6IN88US=>NYDZWGxuW0GQR1XS
GDM-1M{LVZWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MnqwTWM2OD1yLkCxPFM{KM7:TR?=NYjkfY1tW0GQR1XS
AN3-CAM3Lne2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NY\1NpNlUUN3ME2wMlAyQDd|IN88US=>NF;HWYxUSU6JRWK=
BL-70NFfjPIFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NXHQb2tXUUN3ME2wMlAzOTl7IN88US=>NUjseJdUW0GQR1XS
DaudiMmXLS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M3fTN2lEPTB;MD6wNlU{PyEQvF2=NIXJeZpUSU6JRWK=
KU812NWS3SYw4T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NVK0OZFZUUN3ME2wMlAzQDR6IN88US=>NFflRWZUSU6JRWK=
KG-1NV\SbWtsT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NIHYZZdKSzVyPUCuNFMzQTRizszNMV3TRW5ITVJ?
DOHH-2NFjkRYZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MnvXTWM2OD1yLkC0PFA{KM7:TR?=NYnwVYkyW0GQR1XS
HuO9NIrhcHBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M1H2dWlEPTB;MD6wOVQ1QCEQvF2=NGfE[ZZUSU6JRWK=
EB2M2DPVGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MVTJR|UxRTBwMEW1O|Yh|ryPMmnjV2FPT0WU
G-402MUjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MW\JR|UxRTBwME[zOFEh|ryPM2rw[HNCVkeHUh?=
SU-DHL-1MV7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NGr0eJpKSzVyPUCuNFY{PzlizszNNYHh[oVlW0GQR1XS
NCI-H719MVzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MXzJR|UxRTBwMEe4PFgh|ryPNF;4NY5USU6JRWK=
MLMANGHmOXBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MXXJR|UxRTBwMEmwOkDPxE1?M2LmWnNCVkeHUh?=
KM12MnTBS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MmDMTWM2OD1yLkC5O|M4KM7:TR?=MVzTRW5ITVJ?
SUP-T1MV;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NHTOXphKSzVyPUCuNFk6QDJizszNM2DidXNCVkeHUh?=
MZ1-PCNFX4TZhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MlLETWM2OD1yLkGxN|M3KM7:TR?=NEPldWxUSU6JRWK=
MFE-296MnnoS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M3jhdmlEPTB;MD6xNVg{QSEQvF2=Mk\CV2FPT0WU
ALL-PONX;iV5plT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1j0S2lEPTB;MD6xNlQ1OyEQvF2=NXTsdJFtW0GQR1XS
GB-1Mk[5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NEO5eVJKSzVyPUCuNVI2OTJizszNNFjpbZRUSU6JRWK=
SIG-M5NWT5bXNPT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NGfJWI5KSzVyPUCuNVM{PyEQvF2=NGHjXnlUSU6JRWK=
P30-OHKNYn4ZllXT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NF7uZXZKSzVyPUCuNVU3PzJizszNM3;TVXNCVkeHUh?=
NCI-H716M{DPO2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NFm2ZXNKSzVyPUCuNVYzPjZizszNMmHMV2FPT0WU
MPP-89MojkS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NV;xepZMUUN3ME2wMlE3QTN|IN88US=>NGfmSppUSU6JRWK=
SF126M2\3WWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MUjJR|UxRTBwMUewOlMh|ryPMkP2V2FPT0WU
CTB-1NXrCXnd5T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NV32[VhnUUN3ME2wMlE4OzF4IN88US=>MWrTRW5ITVJ?
CA46MVTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M1vvcGlEPTB;MD6xO|Q5QSEQvF2=MUPTRW5ITVJ?
NCI-H520MmXFS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MnnvTWM2OD1yLkG3O|MzKM7:TR?=MmnUV2FPT0WU
CAL-85-1MkLRS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M1vqOGlEPTB;MD6xO|kzPyEQvF2=MnHDV2FPT0WU
NCI-H2342MX3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NH3LWm9KSzVyPUCuNVg2PzdizszNNXuxeZpJW0GQR1XS
697NHvs[ZJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MUDJR|UxRTBwMUi4O|Eh|ryPMVLTRW5ITVJ?
NYMl3nS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NGXpXYRKSzVyPUCuNVkzQDdizszNM4rtOXNCVkeHUh?=
T98GMn;6S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NIrpTZVKSzVyPUCuNVk{OThizszNMkfhV2FPT0WU
NCI-H1703MkD4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NV23bWk{UUN3ME2wMlE6PjF3IN88US=>M2DZWnNCVkeHUh?=
NCI-H2087M4rTdWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NFryV3lKSzVyPUCuNlA1OzlizszNNF;KcWlUSU6JRWK=
PF-382NIPWOppIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MYTJR|UxRTBwMkC4O|Mh|ryPNWTiNWF{W0GQR1XS
HCT-116NXzzNFdET3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=Mn\2TWM2OD1yLkKxNFY6KM7:TR?=Mmr4V2FPT0WU
CAKI-1NX;EWYl2T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NF7uTFZKSzVyPUCuNlE3PjZizszNNUjYXGt[W0GQR1XS
CCF-STTG1NFfTbZRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NVvSOJJJUUN3ME2wMlIzPDd3IN88US=>NIT3SZdUSU6JRWK=
D-392MGNFGxdotIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MnXXTWM2OD1yLkKzNVc4KM7:TR?=M1r3N3NCVkeHUh?=
RT-112M1X5cGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M1ztSmlEPTB;MD6yN|c6PSEQvF2=MYrTRW5ITVJ?
MES-SAM3;HZWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M{jINGlEPTB;MD6yOFE5PyEQvF2=MUTTRW5ITVJ?
LC-2-adM3;3S2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MXXJR|UxRTBwMkSyOlUh|ryPM3vwU3NCVkeHUh?=
NOS-1MWDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MmHDTWM2OD1yLkK0N|Y4KM7:TR?=MV3TRW5ITVJ?
NALM-6NVnXTG9oT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NH\rdYJKSzVyPUCuNlU2PDNizszNMXLTRW5ITVJ?
TE-15MkHKS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M4m2XGlEPTB;MD6yOlA6OSEQvF2=NHnW[HZUSU6JRWK=
786-0NYXsfI9HT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NVnTSmxsUUN3ME2wMlI3OjJ6IN88US=>MWDTRW5ITVJ?
IST-MES1MnnwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M4HEWWlEPTB;MD6yOlgzQSEQvF2=M4LxXXNCVkeHUh?=
KYSE-180MoCzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M33XNmlEPTB;MD6yOlg6OSEQvF2=M{WwdnNCVkeHUh?=
YTMWrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M1\KUGlEPTB;MD6yOlk4PCEQvF2=NXv4N25QW0GQR1XS
A427NIW2UZNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MWHJR|UxRTBwMkeyOlQh|ryPNIr4S|JUSU6JRWK=
KYSE-450MlXHS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MYnJR|UxRTBwMkezNlkh|ryPNFryOJpUSU6JRWK=
HuH-7M{Tncmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NECxVVFKSzVyPUCuNlc4PjNizszNNIXuUHdUSU6JRWK=
CAS-1MVXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M3;oSmlEPTB;MD6yPFMxOyEQvF2=MkflV2FPT0WU
KURAMOCHINETyS2NIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NH\jcnFKSzVyPUCuNlg1OTlizszNM1z2WXNCVkeHUh?=
ACHNMnXCS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MXjJR|UxRTBwMkmzNlMh|ryPNF\wWFJUSU6JRWK=
HGC-27NFvzbWtIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MWHJR|UxRTBwMkmzOVMh|ryPNHSyVoVUSU6JRWK=
A172NUKx[Wp5T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MkPDTWM2OD1yLkK5OVc4KM7:TR?=MlHMV2FPT0WU
SNU-449MX7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NVHaO5gzUUN3ME2wMlI6QTZ2IN88US=>NYnzcYZNW0GQR1XS
SW982NEC1T|JIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MneyTWM2OD1yLkK5PVc5KM7:TR?=MV;TRW5ITVJ?
EFO-21M4HLcmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NWDMTnNuUUN3ME2wMlMxPDFzIN88US=>MUHTRW5ITVJ?
NCI-H2030NUXIfHh2T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1vKT2lEPTB;MD6zNVE3PCEQvF2=MYTTRW5ITVJ?
HT-144MYHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NULMR3dMUUN3ME2wMlMyOjhizszNNXrMTphZW0GQR1XS
MFE-280MmrWS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NYnId4FiUUN3ME2wMlMyPDV|IN88US=>NGjiVnhUSU6JRWK=
SK-LU-1MnPhS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MY\JR|UxRTBwM{G0OlYh|ryPMmi0V2FPT0WU
NCI-H2052M{D0OGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M{H2UWlEPTB;MD6zNVQ5PCEQvF2=MWHTRW5ITVJ?
SK-HEP-1NFXhfYNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MYrJR|UxRTBwM{OzOlgh|ryPNGLISGpUSU6JRWK=
QIMR-WILMVHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MnzMTWM2OD1yLkOzOFI1KM7:TR?=MlywV2FPT0WU
A2780NEGxfXVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Mki5TWM2OD1yLkO0N|A1KM7:TR?=MXjTRW5ITVJ?
ACNM4PWUWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M4PpOGlEPTB;MD6zOFg4OyEQvF2=NG[5TXpUSU6JRWK=
BxPC-3MlfBS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NHHh[ZRKSzVyPUCuN|Q6QDlizszNNUPTNoJZW0GQR1XS
BCPAPM3vTSmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M1P2[2lEPTB;MD6zOlAxOSEQvF2=NH\SPW9USU6JRWK=
HOP-62NH;6UWhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M1XrVmlEPTB;MD6zOlExPiEQvF2=NIDISHhUSU6JRWK=
SW1710NWLIRlNQT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MXPJR|UxRTBwM{[0OVUh|ryPMXvTRW5ITVJ?
OPM-2Ml;SS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MnHmTWM2OD1yLkO2OFc{KM7:TR?=MWnTRW5ITVJ?
DBTRG-05MGM3TscWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NEKyNZRKSzVyPUCuN|gxPTRizszNNH;FRWZUSU6JRWK=
SK-MEL-24MkDKS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MmfUTWM2OD1yLkO5O|kyKM7:TR?=NWToVYlEW0GQR1XS
8305CNWDlWpR4T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1f5OGlEPTB;MD6zPVc6OyEQvF2=NWrhR5FKW0GQR1XS
OVCAR-4M3LOR2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NF\NZnJKSzVyPUCuOFE2QDZizszNMUjTRW5ITVJ?
HLEMY\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MYnJR|UxRTBwNEG4OkDPxE1?NY\pVXQ1W0GQR1XS
NCI-H747NUewZm1DT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MX\JR|UxRTBwNEKxN|ch|ryPNGTPW5VUSU6JRWK=
SW780MlvxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MYrJR|UxRTBwNEKzOFYh|ryPMXjTRW5ITVJ?
KYSE-150MnjHS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NWXpU|lxUUN3ME2wMlQzPDF3IN88US=>NWLNc281W0GQR1XS
H4NXH6[pNYT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M{XQbWlEPTB;MD60NlQ2OSEQvF2=NWfzbGtuW0GQR1XS
SW1088MWXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M{fWUmlEPTB;MD60OFM6KM7:TR?=NVX0N|JMW0GQR1XS
SF268NGH3eIVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MmfXTWM2OD1yLkS0PFYh|ryPMlnaV2FPT0WU
RT4NYqyd445T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=Mkj3TWM2OD1yLkS1NVEyKM7:TR?=MnnFV2FPT0WU
NCI-H522MX7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M3mzemlEPTB;MD60OVI4KM7:TR?=MVHTRW5ITVJ?
LCLC-97TM1M1vNZmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M{\5WGlEPTB;MD60OlE6PSEQvF2=MnnlV2FPT0WU
CAL-39M{fUXGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NIXyPWpKSzVyPUCuOFY2OTlizszNNICwbXhUSU6JRWK=
CAL-120MX7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MYDJR|UxRTBwNEe2OFMh|ryPNFX6foJUSU6JRWK=
ESS-1M4D6dWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NHTCN|JKSzVyPUCuOFc5OjFizszNM1LMcnNCVkeHUh?=
KARPAS-45MY\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NFnFZVVKSzVyPUCuOFg6OzNizszNM1PRWXNCVkeHUh?=
DU-4475MmXaS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NUexSJdvUUN3ME2wMlQ6PTFzIN88US=>NFX4dZJUSU6JRWK=
VMRC-RCZMX\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NWfDXHUyUUN3ME2wMlQ6QTB2IN88US=>NInRZ3NUSU6JRWK=
HOSMU\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MofRTWM2OD1yLkWwN|Y2KM7:TR?=MX3TRW5ITVJ?
MOLT-16M1PLbmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MVHJR|UxRTBwNUG4NFgh|ryPMliyV2FPT0WU
RPMI-6666MnTqS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MXvJR|UxRTBwNUKxN|Uh|ryPNV7ING85W0GQR1XS
K052MmPUS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MkC1TWM2OD1yLkWyNVQh|ryPMXrTRW5ITVJ?
EHEBMUfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NGCwfVNKSzVyPUCuOVIyQDJizszNM{S0c3NCVkeHUh?=
MFH-inoMkP5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M{jZOWlEPTB;MD61NlM2OSEQvF2=MlKzV2FPT0WU
A4-FukM2WxVmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7Mlu1TWM2OD1yLkWyOVI5KM7:TR?=NUnDZYsxW0GQR1XS
SW1417M1v2SWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M{nJVmlEPTB;MD61Nlc5OSEQvF2=MmL5V2FPT0WU
DoTc2-4510M3;DeGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MV;JR|UxRTBwNUS5OVgh|ryPNVvIWVdrW0GQR1XS
TE-12MULHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MmH5TWM2OD1yLkW1O|M2KM7:TR?=MVzTRW5ITVJ?
8-MG-BANF3oWoVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Mn[5TWM2OD1yLkW2NFU3KM7:TR?=M2S0RnNCVkeHUh?=
ECC12Mnm0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NXnBbItyUUN3ME2wMlU3PTV6IN88US=>NHfsTYJUSU6JRWK=
CHL-1M13mfWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NHH2enhKSzVyPUCuOVc1PjNizszNMYrTRW5ITVJ?
LCLC-103HMmHiS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MVPJR|UxRTBwNUizOFQh|ryPM33Ve3NCVkeHUh?=
OS-RC-2NXO4XFF3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MVPJR|UxRTBwNUizO|kh|ryPMmnnV2FPT0WU
RO82-W-1MnXCS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NIOzdHlKSzVyPUCuOVk3OTVizszNNFLEVZJUSU6JRWK=
A3-KAWMXLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M4[z[GlEPTB;MD62NVQ3PyEQvF2=NWi3PHNyW0GQR1XS
NCCITNEO1XFNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MkTZTWM2OD1yLk[xO|E2KM7:TR?=M1XXV3NCVkeHUh?=
IST-SL2M1nTWmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MX\JR|UxRTBwNkK1NlIh|ryPMnv5V2FPT0WU
GI-ME-NMl3XS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MWnJR|UxRTBwNkOwOlkh|ryPNX[xU2w1W0GQR1XS
ES6NYC0ZpRDT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NVHPPYs6UUN3ME2wMlY{Ojl3IN88US=>NXL0XIt7W0GQR1XS
BL-41MUTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M1T6XGlEPTB;MD62N|M2OiEQvF2=NV3oR21kW0GQR1XS
Ca-SkiNVjOfmlKT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MnXNTWM2OD1yLk[0PFEh|ryPM4\2bHNCVkeHUh?=
HOP-92M1;rWGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7Ml7zTWM2OD1yLk[1OlczKM7:TR?=NGjvZoxUSU6JRWK=
SK-LMS-1MVnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M1TXW2lEPTB;MD62OlQ4KM7:TR?=MWrTRW5ITVJ?
EW-13NYnXSJlqT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MnPhTWM2OD1yLk[2O|c6KM7:TR?=NGfLdWVUSU6JRWK=
647-VMXvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MVnJR|UxRTBwNkixOFgh|ryPMUfTRW5ITVJ?
JiyoyeP-2003NUPoNVBZT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MXHJR|UxRTBwNkm3N|gh|ryPM{D1c3NCVkeHUh?=
WSU-NHLNGXFbYlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M2PzVmlEPTB;MD63NFg5PyEQvF2=Mkf6V2FPT0WU
U-698-MNYnyeHZiT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MV3JR|UxRTBwN{GwOlMh|ryPM3n6dHNCVkeHUh?=
HC-1NYTzPGE6T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MVrJR|UxRTBwN{K0NFUh|ryPMWfTRW5ITVJ?
8505CNE\BOINIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MlHaTWM2OD1yLkeyO|QyKM7:TR?=NGmwfVdUSU6JRWK=
HUTU-80NGjSUZpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MlziTWM2OD1yLkezN|Q6KM7:TR?=M3fZRXNCVkeHUh?=
LB1047-RCCMVHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NU\oVIlqUUN3ME2wMlc{PTN6IN88US=>NV61[5NrW0GQR1XS
GAMGMVfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MoP5TWM2OD1yLkezOlU{KM7:TR?=NX;vVlg3W0GQR1XS
CAL-12TM1\VdWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MoDsTWM2OD1yLkezPFc4KM7:TR?=M{KwXXNCVkeHUh?=
NCI-SNU-1NW\WWXFST3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M4TQWWlEPTB;MD63O|I4QCEQvF2=NEi1S4NUSU6JRWK=
HTC-C3MUPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MULJR|UxRTBwN{e0OVEh|ryPMWDTRW5ITVJ?
HPAF-IIMlLHS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MkHqTWM2OD1yLke3OVAyKM7:TR?=MVTTRW5ITVJ?
KGNMUfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NUPlR|RVUUN3ME2wMlc5ODhzIN88US=>MX;TRW5ITVJ?
EFO-27MlzjS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M1\2eWlEPTB;MD63PFc{OyEQvF2=M17EWnNCVkeHUh?=
MEL-HONY\veGllT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MYjJR|UxRTBwN{m0OFkh|ryPNUS2[VQzW0GQR1XS
KYSE-270M3P4R2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7M4raZ2lEPTB;MD64NFUzQSEQvF2=Mor0V2FPT0WU
NCI-H1755MXnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NYi2RXRDUUN3ME2wMlgxPzF2IN88US=>MV7TRW5ITVJ?
MFM-223NX21RW1pT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MWXJR|UxRTBwOEG0NFch|ryPMVnTRW5ITVJ?
G-361NGrVRW9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MX;JR|UxRTBwOEG4PVch|ryPM4G1WXNCVkeHUh?=
ETK-1NWHpVoVpT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NYnpeJhSUUN3ME2wMlgzPDRzIN88US=>NHf6cYJUSU6JRWK=
LU-99AMX\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NV:yfJFlUUN3ME2wMlg1PzBzIN88US=>Ml7ZV2FPT0WU
IST-MEL1Mo\RS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M{HHcWlEPTB;MD64OVc{OiEQvF2=MWTTRW5ITVJ?
L-540MlvsS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M2fSZmlEPTB;MD64OVgxOSEQvF2=NVnlNGh[W0GQR1XS
U-2-OSNWDyTGNzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M4izb2lEPTB;MD64OVg1PiEQvF2=M3zGbnNCVkeHUh?=
HT-1376NIThZ|dIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NEHXXmNKSzVyPUCuPFYxPTFizszNNWniRoNNW0GQR1XS
COLO-680NMWDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NV;qeXBqUUN3ME2wMlg4QTN|IN88US=>NXH5U5l1W0GQR1XS
NCI-H1581M37TXWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MVfJR|UxRTBwOEmyPVch|ryPNGTCfpJUSU6JRWK=
HuCCT1M1zoSmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MUHJR|UxRTBwOEm1OFgh|ryPM4nXdXNCVkeHUh?=
BB30-HNCNIj6NGFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M1PoV2lEPTB;MD65NlQ3QSEQvF2=NEDKdm9USU6JRWK=
NCI-H2347NGLYcWVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NVjjZnZDUUN3ME2wMlk{Ojl{IN88US=>NX30R5F{W0GQR1XS
G-401M4[xWmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NGHHVnVKSzVyPUCuPVM3QTVizszNM3XZZ3NCVkeHUh?=
NCI-H358NYLifHlPT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M2XO[GlEPTB;MD65OVAyPCEQvF2=MnfhV2FPT0WU
HCC1395NFnHRXRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MVnJR|UxRTBwOUW0OlEh|ryPM3vYT3NCVkeHUh?=
J82MofHS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MV7JR|UxRTBwOUW1OFMh|ryPMXrTRW5ITVJ?
KE-37M333PGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NIHxcppKSzVyPUCuPVY{QDdizszNMUjTRW5ITVJ?
NOMO-1NHm1V5hIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MXLJR|UxRTBwOU[1OlQh|ryPNH7WbZdUSU6JRWK=
ML-2NV\QTFZ[T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1zPW2lEPTB;MD65PVc2KM7:TR?=M3T1SnNCVkeHUh?=
SW872NG\keI1Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NGnX[4dKSzVyPUCuPVk4PzVizszNMkHCV2FPT0WU
KYSE-520MoTVS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MWXJR|UxRTFwMEC0PVQh|ryPMVfTRW5ITVJ?
HL-60NVH1Oo9zT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NX\ZOYE1UUN3ME2xMlAxQTdizszNNWLsSXYyW0GQR1XS
HDLM-2MnrRS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NFzJbIJKSzVyPUGuNFEzPTJizszNMoG0V2FPT0WU
MIA-PaCa-2MmqzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MojsTWM2OD1zLkCxN|c2KM7:TR?=MUXTRW5ITVJ?
TCCSUPNFP0VmNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MYjJR|UxRTFwMEG3N|Ih|ryPM3LVd3NCVkeHUh?=
SH-4MUPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NIDn[VlKSzVyPUGuNFIzPDRizszNNVrmTIdZW0GQR1XS
MG-63NUC0d2Q2T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NHzScoVKSzVyPUGuNFI3OTZizszNMV;TRW5ITVJ?
NB6MU\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M4nuUmlEPTB;MT6wN|ExQSEQvF2=NGDTdWRUSU6JRWK=
CAL-54NUDHOJBqT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MljiTWM2OD1zLkCzPVU6KM7:TR?=NEnFZ2JUSU6JRWK=
DU-145M2KzPWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7Mn20TWM2OD1zLkC4NFc{KM7:TR?=NH;Xe3FUSU6JRWK=
HCE-4NH;IdoVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NYPHPHRCUUN3ME2xMlA6Ojh4IN88US=>MY\TRW5ITVJ?
U-266NIPWSZpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MX\JR|UxRTFwMEm2N|Mh|ryPMlzXV2FPT0WU
HT-1197MmLlS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M4jIemlEPTB;MT6xNVQ{QCEQvF2=NYHTZ3F[W0GQR1XS
EW-1NX\LVJJnT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NIW3XodKSzVyPUGuNVQyOjhizszNMkHXV2FPT0WU
MHH-NB-11M{TY[mdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MUnJR|UxRTFwMUWzOlgh|ryPM{nzOHNCVkeHUh?=
NCI-H2405NYPzb4NST3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NUXWUId[UUN3ME2xMlE3OTZizszNM4XTPXNCVkeHUh?=
COLO-668MnPLS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NVX0NY9pUUN3ME2xMlE3PDlizszNNHvjbplUSU6JRWK=
IMR-5MojWS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NGTNSo1KSzVyPUGuNVY6OzZizszNMnXPV2FPT0WU
ARH-77NUX4W41RT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NW\nbY9qUUN3ME2xMlIzQTJ2IN88US=>M3HoVnNCVkeHUh?=
BHT-101M17pe2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7M1nLemlEPTB;MT6yN|Q6KM7:TR?=NFz2WGZUSU6JRWK=
SCC-25NXTvUYE1T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MWDJR|UxRTFwMkO1N|Yh|ryPNUHXR3BnW0GQR1XS
NTERA-S-cl-D1NFHWdWFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MkfqTWM2OD1zLkK0N|Q3KM7:TR?=MVzTRW5ITVJ?
MKN28NGnQOYxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MY\JR|UxRTFwMkW2N|Yh|ryPM4DNSXNCVkeHUh?=
KS-1NVXEeHdCT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1f4[2lEPTB;MT6yPFI3QSEQvF2=MUPTRW5ITVJ?
NCI-H1734Mn3SS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MnryTWM2OD1zLkK4PVE{KM7:TR?=M4mxSXNCVkeHUh?=
ES7MWnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NWixe2k{UUN3ME2xMlI6PTR{IN88US=>MVLTRW5ITVJ?
NCI-H838NEDq[ZBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MX7JR|UxRTFwM{C2NVUh|ryPMm\FV2FPT0WU
HEC-1M2XPS2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7M{jIb2lEPTB;MT6zN|c2PSEQvF2=NUPHXYZ6W0GQR1XS
ME-180NY[yfIJ4T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NH;GUXBKSzVyPUGuN|c6QTNizszNMULTRW5ITVJ?
MMAC-SFNFXNPXJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MWrJR|UxRTFwM{m1PVUh|ryPM3raSXNCVkeHUh?=
IA-LMM2\zdWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M4rlXGlEPTB;MT60NFkyPCEQvF2=M4fL[HNCVkeHUh?=
MN-60MoLIS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MmXsTWM2OD1zLkSzNVE1KM7:TR?=MlvrV2FPT0WU
SIMANXrnfoQ4T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NYr1boNVUUN3ME2xMlQ5Pjh5IN88US=>M1[1W3NCVkeHUh?=
NCI-H1770NH31Xo9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NIHkNoNKSzVyPUGuOVIxPTRizszNNVjuNnp7W0GQR1XS
ONS-76NETZN5ZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M3H5OWlEPTB;MT61NlMyOSEQvF2=Mkn1V2FPT0WU
LB771-HNCMVHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NUHafVQxUUN3ME2xMlU{QTB4IN88US=>NGrVOItUSU6JRWK=
SW48M3rKT2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NI[1co5KSzVyPUGuOVQzPDNizszNNYiwVIYzW0GQR1XS
KYSE-140NH\keG9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NGfYVnhKSzVyPUGuOVU4PDFizszNNUPFZ3loW0GQR1XS
SW626MUjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M{jyeGlEPTB;MT61PFE3KM7:TR?=MYjTRW5ITVJ?
MC-CARMn30S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M17yZWlEPTB;MT61PFY3OyEQvF2=Mk\xV2FPT0WU
D-336MGMmj5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M1LJSWlEPTB;MT62Nlk1KM7:TR?=NUHHdmpbW0GQR1XS
SK-MEL-3M2iz[Wdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MUnJR|UxRTFwNkO5NFIh|ryPNHTUOHBUSU6JRWK=
MHH-PREB-1NGLJZ5hIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M2LCR2lEPTB;MT62OFQ4OyEQvF2=Ml;DV2FPT0WU
Calu-1M3\lfGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MkTZTWM2OD1zLk[1N|g3KM7:TR?=NGDB[XJUSU6JRWK=
HCC1806MmHVS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M3;vdWlEPTB;MT62OlYyOSEQvF2=NF\INZJUSU6JRWK=
A101DNWj0[VlFT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1fCOmlEPTB;MT62Olc5OSEQvF2=NXL2[oZYW0GQR1XS
A704M1S5[Gdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NVfRU5BHUUN3ME2xMlY5OzFzIN88US=>MV\TRW5ITVJ?
LB831-BLCM1zTc2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7M3LWcmlEPTB;MT62PVg2PCEQvF2=MnXRV2FPT0WU
RL95-2NHTtPVlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NIK1PI5KSzVyPUGuO|E1PjNizszNNHzScXpUSU6JRWK=
RPMI-2650MWDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NFy1TXVKSzVyPUGuO|I4OTlizszNNHH4S49USU6JRWK=
NH-12NFzUOphIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MVjJR|UxRTFwN{O0Nlch|ryPMoPCV2FPT0WU
AGSNUnvSHROT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NY\NXoRwUUN3ME2xMlc3OzV6IN88US=>NEnaR5ZUSU6JRWK=
NEC8NEXlVIVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MnPNTWM2OD1zLke4PVk2KM7:TR?=NHrkV5BUSU6JRWK=
NCI-H2009NHv0ZZNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NHy2fXZKSzVyPUGuO|k4OjFizszNMl2xV2FPT0WU
A498M3rKSWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MYTJR|UxRTFwOEGyPFIh|ryPNHXSempUSU6JRWK=
NCI-H810MnvBS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M2rXXWlEPTB;MT64NVYxPiEQvF2=M4\LdnNCVkeHUh?=
SK-NEP-1NHX2NXBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Mn;LTWM2OD1zLkizO|Y4KM7:TR?=M2HHUnNCVkeHUh?=
D-542MGNUXOdY1xT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M3\tT2lEPTB;MT64OVg2OSEQvF2=MkHlV2FPT0WU
KNS-42MmC0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MYTJR|UxRTFwOE[yOlYh|ryPMYDTRW5ITVJ?
NCI-H2452NYPQVoxxT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MX3JR|UxRTFwOEmwO|Qh|ryPNX3pV|QzW0GQR1XS
SK-MEL-2MWDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M3PXemlEPTB;MT65NFI4OSEQvF2=MUDTRW5ITVJ?
OVCAR-5NV;pWY9UT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MkDqTWM2OD1zLkmwOlc2KM7:TR?=NICxcHpUSU6JRWK=
SNG-MNVrvZ2xVT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NUO1dFdUUUN3ME2xMlk2QDV6IN88US=>NYj0XplnW0GQR1XS
A673NU\GXHJIT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NFzae2lKSzVyPUGuPVc2OTZizszNM1vSRnNCVkeHUh?=
L-428M4Lzbmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NYHnNo9xUUN3ME2xMlk6OTd7IN88US=>NX3ISVRtW0GQR1XS
KM-H2MkLaS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NInxTo1KSzVyPUKuNFExQSEQvF2=MoXPV2FPT0WU
MC-IXCNGm3NHRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NWjkUJE6UUN3ME2yMlAzOjd|IN88US=>MVTTRW5ITVJ?
COLO-678MkTBS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M1\5WWlEPTB;Mj6wOFIxPyEQvF2=MXTTRW5ITVJ?
MEL-JUSOM{fiUmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NXzQOVRYUUN3ME2yMlA4QDVzIN88US=>NWTmT|BUW0GQR1XS
HCC38NVXucllzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MkLpTWM2OD1{LkC4OFM{KM7:TR?=NUD4dHIyW0GQR1XS
UACC-62MlzpS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NUnDZoRGUUN3ME2yMlA5QDV3IN88US=>M3fzOXNCVkeHUh?=
OAW-42NYnlNXZtT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MlXSTWM2OD1{LkC5O|EyKM7:TR?=MYHTRW5ITVJ?
LB996-RCCMmfvS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M2jieGlEPTB;Mj6xN|gyPyEQvF2=M3rWbnNCVkeHUh?=
COR-L105MVHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MXLJR|UxRTJwMU[zO|Mh|ryPNEjtU2tUSU6JRWK=
RCC10RGBM2T1e2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MX7JR|UxRTJwMUi1O|Yh|ryPMnftV2FPT0WU
A431NFrJN41Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MlXqTWM2OD1{LkG5NFE6KM7:TR?=MYjTRW5ITVJ?
NCI-H292MUPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MnPjTWM2OD1{LkKzPVUyKM7:TR?=MW\TRW5ITVJ?
SK-UT-1NYi0WlV5T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NWnU[JI6UUN3ME2yMlM{OTh2IN88US=>MXXTRW5ITVJ?
PANC-08-13Mn:5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NIHiUVNKSzVyPUKuN|MzOzVizszNNVn2OnNMW0GQR1XS
ST486M4XFRmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M2HOfmlEPTB;Mj60NVA1QCEQvF2=MmXzV2FPT0WU
SJSA-1NVS4Z4dHT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NVTwTYpKUUN3ME2yMlQyOjdzIN88US=>NXjuPWIzW0GQR1XS
RKOMXXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M4jOU2lEPTB;Mj60NlAzQSEQvF2=NXrlOIpiW0GQR1XS
NCI-H1793M1nS[2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MYPJR|UxRTJwNESwNlkh|ryPNHL4U5hUSU6JRWK=
639-VMl:2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MUTJR|UxRTJwNEWzPFIh|ryPNWHxOG11W0GQR1XS
ES3MoL1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NUDLfGFkUUN3ME2yMlQ6PzN5IN88US=>MWLTRW5ITVJ?
NCI-H1792M2PLeGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MWnJR|UxRTJwNU[4NlYh|ryPM37UcHNCVkeHUh?=
NCI-H1651Mn\vS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NXf4NY9yUUN3ME2yMlU5OjFizszNMlyyV2FPT0WU
SN12CMYPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NGeycYpKSzVyPUKuOVg1QDdizszNNY\lPXBFW0GQR1XS
COLO-679MXLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MV;JR|UxRTJwNUi2NFUh|ryPMmHIV2FPT0WU
U-118-MGNHPX[3lIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NWHOU|l6UUN3ME2yMlU5QDd{IN88US=>NYnKO|ZzW0GQR1XS
Ramos-2G6-4C10NWK5fooxT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MV3JR|UxRTJwNkS4NFch|ryPNVPXT|FJW0GQR1XS
HCT-15NH3kXm5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MnPwTWM2OD1{Lk[4O|kzKM7:TR?=M17BOHNCVkeHUh?=
MDA-MB-157MYjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NIf3ZZBKSzVyPUKuO|A4PDdizszNMmTmV2FPT0WU
K5NIXvUoVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M{DHOmlEPTB;Mj63NVg1PSEQvF2=NITuT2hUSU6JRWK=
MKN45NIjDV3pIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NYrtN|l6UUN3ME2yMlc{OzZ4IN88US=>NGj0OoNUSU6JRWK=
DMS-273NH6yfmdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NYH5Z4xMUUN3ME2yMlc2PjN{IN88US=>M{nwR3NCVkeHUh?=
C8166MX;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NIn5cGRKSzVyPUKuO|g2OTNizszNNYT6W49xW0GQR1XS
Calu-3NUX4dYU2T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=Ml;kTWM2OD1{Lke4PVY6KM7:TR?=NEfNR3ZUSU6JRWK=
SNB75MXjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MXHJR|UxRTJwOEi1N|Uh|ryPMX7TRW5ITVJ?
BFTC-905NF3PZWlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MWLJR|UxRTJwOUCxPVEh|ryPNVrLXZlGW0GQR1XS
C-4-IINIj5V3NIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NXPydWxHUUN3ME2yMlkyOzV|IN88US=>NIToZpRUSU6JRWK=
MS-1NGLweWhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NIrN[HZKSzVyPUKuPVY4PjlizszNMUTTRW5ITVJ?
A375MUjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NWTifHFiUUN3ME2zMlA5OTh2IN88US=>MX;TRW5ITVJ?
KYSE-70NHHVXlhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NUPLTG5DUUN3ME2zMlA5QDh{IN88US=>NV7DS3FvW0GQR1XS
KYSE-510NHjsUVZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NYHxenJWUUN3ME2zMlExQTl3IN88US=>NWHBR3k5W0GQR1XS
LN-405NFrjN41Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MoDQTWM2OD1|LkGzOVE5KM7:TR?=M{\RcnNCVkeHUh?=
BOKUNITmUFdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M2PhRmlEPTB;Mz6xOFI2PiEQvF2=MnfkV2FPT0WU
TE-10NWOyeIZqT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MVPJR|UxRTNwMUezOlIh|ryPMknzV2FPT0WU
MKN1M3TZe2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7M1v0O2lEPTB;Mz6xPFQ5OyEQvF2=MmLOV2FPT0WU
M059JMnHNS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MoLOTWM2OD1|LkKwNVc{KM7:TR?=NVzJWWxvW0GQR1XS
GOTOM4DlS2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NGP0SIhKSzVyPUOuNlIxOzlizszNMoLxV2FPT0WU
DK-MGM3LJRmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NGPNcJFKSzVyPUOuNlU6PzZizszNMWfTRW5ITVJ?
NCI-H727M1vEb2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7M37SPGlEPTB;Mz6yOlU5KM7:TR?=MUfTRW5ITVJ?
NB12MkjIS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NUXS[nhxUUN3ME2zMlM{OjJ2IN88US=>NGDCNm1USU6JRWK=
DOKM1nU[mdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MWHJR|UxRTNwM{[xPFYh|ryPMorTV2FPT0WU
KYSE-410MkHXS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M{TEcmlEPTB;Mz6zOlI5PyEQvF2=NWTHbIFDW0GQR1XS
AM-38MW\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M3ryPWlEPTB;Mz6zPFA2OSEQvF2=NULjdVdQW0GQR1XS
GR-STNVHSVXVzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MofMTWM2OD1|LkS1O|MzKM7:TR?=M2XoXXNCVkeHUh?=
D-247MGM{LNU2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7M4W1RWlEPTB;Mz60PFI3OyEQvF2=NYPweGtLW0GQR1XS
TE-8M1yzNGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M1rLd2lEPTB;Mz60PVM{OyEQvF2=M2rZcXNCVkeHUh?=
LS-411NM{\FOmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MUjJR|UxRTNwNEm2PVIh|ryPMVXTRW5ITVJ?
SK-MES-1MnnES5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NX;rRmx7UUN3ME2zMlU3PDN|IN88US=>M1no[nNCVkeHUh?=
SF295M4\Fdmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NGLEUpFKSzVyPUOuOlE2PTJizszNM3jZU3NCVkeHUh?=
SK-MEL-30NFLGR|ZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NIn2ZnZKSzVyPUOuOlU6OjFizszNNIXxeHpUSU6JRWK=
LB2241-RCCMorjS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NF3BPG1KSzVyPUOuOlYzPiEQvF2=NGq1[3RUSU6JRWK=
PC-14NX;SfJFYT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M2XJfmlEPTB;Mz62OlQ{PyEQvF2=MofNV2FPT0WU
EW-7MXXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NWHGTpdTUUN3ME2zMlY4Pjl|IN88US=>NV\vU4c2W0GQR1XS
NMC-G1MXfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MUjJR|UxRTNwN{G4N|ch|ryPMWLTRW5ITVJ?
TE-441-TMkixS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M3\US2lEPTB;Mz63N|AzQCEQvF2=NEW4eIlUSU6JRWK=
NCI-H1618M1y2NGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MmLlTWM2OD1|LkixPFc2KM7:TR?=Moi3V2FPT0WU
PANC-03-27MX\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MXHJR|UxRTNwOEG5NVYh|ryPNUfEN5FDW0GQR1XS
NCI-H2228NXnJXoVXT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NInkPYtKSzVyPUOuPFMyOjZizszNMkW5V2FPT0WU
CAPAN-1M4jwcWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NET6PJpKSzVyPUOuPFcxODlizszNM1L0UHNCVkeHUh?=
KLEMUnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M13kXGlEPTB;Mz65NFY4KM7:TR?=NX;kW4x7W0GQR1XS
BeckerM4L4SGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M3\QcmlEPTB;Mz65Nlg1QSEQvF2=M4rObHNCVkeHUh?=
SK-PN-DWNV34N|ZHT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MVPJR|UxRTRwMEe5O|Qh|ryPNFjMfoJUSU6JRWK=
Hs-578-TM4Ts[Gdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MYXJR|UxRTRwMEizNFYh|ryPM2jrUnNCVkeHUh?=
RS4-11NYTidoJrT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NELTbphKSzVyPUSuNVEzPTVizszNNV\sSIc4W0GQR1XS
D-502MGMlnpS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NF7FdpJKSzVyPUSuNVY6QTdizszNMVnTRW5ITVJ?
GI-1MXHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MXjJR|UxRTRwMkiyPVkh|ryPNIfEVZFUSU6JRWK=
NCI-H209NV3xb|BIT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MoPJTWM2OD12LkOzO|gh|ryPMX\TRW5ITVJ?
SK-OV-3M2riVGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MWfJR|UxRTRwNEixOFkh|ryPMl3QV2FPT0WU
LOUCYNXPRS5loT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MlH1TWM2OD12LkS4OFMzKM7:TR?=M{jTWnNCVkeHUh?=
NCI-H69NX3LN5hGT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M4XWRmlEPTB;ND61NVc6OyEQvF2=NUHsZZBiW0GQR1XS
SCC-9Mo\hS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MWfJR|UxRTRwNUOxO|Ih|ryPM{fsbXNCVkeHUh?=
NCI-H526MXrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MlnaTWM2OD12LkW5Nlk{KM7:TR?=M4XoOnNCVkeHUh?=
NCI-H2170NW\DTXJTT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MoflTWM2OD12Lk[2O|cyKM7:TR?=M3mycnNCVkeHUh?=
SRM{O3dGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MmLjTWM2OD12LkewNFQ5KM7:TR?=M{[yO3NCVkeHUh?=
CMKMoXpS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NYjpU5N6UUN3ME20MlczOTBzIN88US=>M1vrOXNCVkeHUh?=
COLO-829NV61fXhjT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M37z[mlEPTB;ND63O|A1OyEQvF2=NVuwTmlRW0GQR1XS
HuO-3N1MXTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NFXkZoNKSzVyPUSuPFMzQDFizszNMoXqV2FPT0WU
5637NH7iPVFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M4L3WmlEPTB;ND65NFQ5PyEQvF2=MV\TRW5ITVJ?
A253NXHYeJNoT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M4PUO2lEPTB;ND65O|cxQCEQvF2=MX7TRW5ITVJ?
NB10NFjpdoJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MVrJR|UxRTVwMEe0PVch|ryPNWLlT3ZoW0GQR1XS
SF539MlH0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MWHJR|UxRTVwMEm5OVkh|ryPNV;yN2xPW0GQR1XS
HAL-01MlrSS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NGXsZmNKSzVyPUWuNVQ3PDVizszNMYHTRW5ITVJ?
MHH-ES-1MUXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M{Hhd2lEPTB;NT6xOlkzPSEQvF2=MkTpV2FPT0WU
DELMl3zS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MmfTTWM2OD13LkK3OVgzKM7:TR?=NVXRRW1CW0GQR1XS
NCI-H1299M1q5eWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MlPnTWM2OD13LkO1NFA4KM7:TR?=MXvTRW5ITVJ?
ChaGo-K-1NWjkOZdjT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=Mk\PTWM2OD13LkO1NVA4KM7:TR?=MnvtV2FPT0WU
HMV-IIMoLKS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M4GzeWlEPTB;NT6zPVQ{KM7:TR?=M4e2UnNCVkeHUh?=
NB69MmX6S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NHm3WXFKSzVyPUWuN|k3OzFizszNMXTTRW5ITVJ?
NCI-H1882NEXENo1Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MXXJR|UxRTVwNEOzOlQh|ryPNILU[5RUSU6JRWK=
SNU-475MWHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NEjwcoNKSzVyPUWuOFcyPzFizszNNVjHUoloW0GQR1XS
RXF393MXLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NEixToRKSzVyPUWuOFg1QTRizszNMXTTRW5ITVJ?
CAL-51MmDnS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M1jOOWlEPTB;NT62Nlg2OyEQvF2=MoX3V2FPT0WU
SW1573NHzQcndIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NHjtfGJKSzVyPUWuOlM2OzRizszNNE\mXVdUSU6JRWK=
GCTMnj0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MYDJR|UxRTVwN{W5Nlkh|ryPNWnTVWMzW0GQR1XS
COR-L88M{XWbmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NX:5bpRJUUN3ME21Mlc3QDR4IN88US=>M2OybnNCVkeHUh?=
MDA-MB-134-VIMVrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M1n2O2lEPTB;NT64O|U{PiEQvF2=M1X3R3NCVkeHUh?=
NB5Mn\aS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M1rEfGlEPTB;NT65NlQ1KM7:TR?=NWnaPXRmW0GQR1XS
GMS-10MlTlS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MXfJR|UxRTVwOU[4OlEh|ryPNU[0b4FLW0GQR1XS
CHP-212MXvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M4jDfGlEPTB;Nj60PFI3PyEQvF2=MYfTRW5ITVJ?
TE-11MVXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M2jubGlEPTB;Nj61OVE5OiEQvF2=NEezd2ZUSU6JRWK=
SW962M3KzOGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7Mn\NTWM2OD14Lk[1O|c1KM7:TR?=NFnCXoZUSU6JRWK=
MZ2-MELM4joOWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M3j6emlEPTB;Nj64NlAyOSEQvF2=MoO0V2FPT0WU
C-33-AMonOS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NVftZXhtUUN3ME22MlkyPjh6IN88US=>MYrTRW5ITVJ?
IGR-1M2\PNWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MXvJR|UxRTZwOUe4NlYh|ryPMn\3V2FPT0WU
MOLT-4M3TuSmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MWrJR|UxRTdwMUW0NFYh|ryPNGfTd4ZUSU6JRWK=
NCI-H1650MXvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NH7tUW1KSzVyPUeuNlcxPDZizszNNHTPSoFUSU6JRWK=
AsPC-1MYXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MY\JR|UxRTdwMki2NFUh|ryPMm\uV2FPT0WU
SNU-C2BM2HBWGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NFHXfnlKSzVyPUeuNlk2PzFizszNNI\MR5JUSU6JRWK=
MKN7M{LTTWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NFTXSFhKSzVyPUeuN|czOzVizszNNVPsTIRqW0GQR1XS
SW620NWrROZhVT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=Ml\yTWM2OD15LkO4NlA2KM7:TR?=NWHWdlNVW0GQR1XS
SK-MEL-28NHXmToVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NH2wXHNKSzVyPUeuOFA4QThizszNMnmwV2FPT0WU
TE-6MmrOS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MYTJR|UxRTdwNES5NFgh|ryPNH6yWHpUSU6JRWK=
D-263MGM4nrbWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MV3JR|UxRTdwNEW3OlIh|ryPMWTTRW5ITVJ?
NCI-H1355NYrqVJFCT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MXfJR|UxRTdwN{ewNlkh|ryPMUPTRW5ITVJ?
DSH1M4HKVmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MX3JR|UxRTdwN{m3OlIh|ryPM4S5NnNCVkeHUh?=
NCI-H460MWjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NHrWeZhKSzVyPUiuNFA3QTRizszNMUPTRW5ITVJ?
NCI-H1563NYfzTocyT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MUfJR|UxRThwMEe1NFgh|ryPMYnTRW5ITVJ?
SW948NXLQbZVCT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MY\JR|UxRThwMUC3OFQh|ryPMmrSV2FPT0WU
LK-2MmXYS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MofmTWM2OD16LkGyPFM{KM7:TR?=M{K0fHNCVkeHUh?=
HT-1080MlT3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MV7JR|UxRThwMUOxO|Uh|ryPNWKxbW4zW0GQR1XS
NCI-H441NFG1b2dIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MXvJR|UxRThwMUmzJO69VQ>?MWnTRW5ITVJ?
HSC-4NIrHZ5dIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NWOwSpJvUUN3ME24MlI5PzJizszNMl\ZV2FPT0WU
LXF-289MlLhS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NUHBZ3dxUUN3ME24MlM2QTR|IN88US=>NYX6XIFvW0GQR1XS
MRK-nu-1MVzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MUTJR|UxRThwM{[zNFQh|ryPNILaW3FUSU6JRWK=
no-11NX6wRVJbT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NGrvZllKSzVyPUiuOFcyOzNizszNM3LFd3NCVkeHUh?=
SNU-387M3f2fGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7Mnn4TWM2OD16Lk[zNlQ3KM7:TR?=NVjtPHFYW0GQR1XS
Detroit562M{Hh[mdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NVjk[IJiUUN3ME24Mlc2PDV3IN88US=>MXfTRW5ITVJ?
SW954M4O1[2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MX3JR|UxRThwN{[4N|Ih|ryPNFX5[4JUSU6JRWK=
P12-ICHIKAWAM2PM[Wdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NX7FfpdbUUN3ME24Mlc5QTRizszNNVvWUoRWW0GQR1XS
TE-9MXfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M17OUWlEPTB;OD64NVA3OiEQvF2=Ml\qV2FPT0WU
NB13NXGwPYw5T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NXnuTVNNUUN3ME24Mlg{Pzl4IN88US=>MV7TRW5ITVJ?
BPH-1M2XtdGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MnvlTWM2OD16Lki1NFgyKM7:TR?=M4L2dXNCVkeHUh?=
KMOE-2MnrOS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M1nnT2lEPTB;OD64O|g6OiEQvF2=NGDEVFNUSU6JRWK=
RPMI-8402NWOzSpRoT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MmPZTWM2OD16Lki5PVI3KM7:TR?=Mn64V2FPT0WU
OVCAR-3MmP5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M4XES2lEPTB;OD65O|c{OiEQvF2=MVPTRW5ITVJ?
NCI-H2196MofpS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MXTJR|UxRThwOUi2NFYh|ryPMYjTRW5ITVJ?
MZ7-melNUnMcIlNT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M2fGUWlEPTB;OT6wN|Q3KM7:TR?=M2fvVXNCVkeHUh?=
GP5dM3PuT2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NVW0fWJxUUN3ME25MlA3OzF|IN88US=>MYPTRW5ITVJ?
NCI-N87MmTDS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NX3ofXh1UUN3ME25MlQ1PzNzIN88US=>NVzxW|liW0GQR1XS
EW-16MoHsS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?Mof0TWM2OD17LkS0PFQ5KM7:TR?=NEjVPWVUSU6JRWK=
Calu-6NWXiR4ViT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NV3hbmk6UUN3ME25MlQ6PzB|IN88US=>M1nJWHNCVkeHUh?=
LC4-1M2GxN2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MYrJR|UxRTlwNkK1O{DPxE1?MnjSV2FPT0WU
CCRF-CEMM3jSSWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MWTJR|UxRTlwNki3OlYh|ryPNEDRW|hUSU6JRWK=
BC-1NIDoVHFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M33lVmlEPTB;OT63PFk6KM7:TR?=MV7TRW5ITVJ?
NCI-SNU-16NELqXJdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Mm[xTWM2OD17Lke5OFk2KM7:TR?=NHvDfnNUSU6JRWK=
NCI-H28NUH5RplvT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MX7JR|UxRTlwOES5N|Mh|ryPMl;hV2FPT0WU
SBC-1NWrPcGFpT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=Mn:2TWM2OD1zMD6wO|Ih|ryPMofwV2FPT0WU
TURMkPaS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NFf5SJBKSzVyPUGwMlE3PTdizszNNFSwfmRUSU6JRWK=
MDA-MB-231Ml76S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NYDzblNiUUN3ME2xNE4zOTF2IN88US=>NV;pc4NGW0GQR1XS
C3ANFTDTVZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NWnKUIhJUUN3ME2xNE4{OTd7IN88US=>M2XvcXNCVkeHUh?=
SW1990M{HkeGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NYT6THFUUUN3ME2xNE4{OjhizszNMYPTRW5ITVJ?
NCI-H1993MoH5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M4HXXWlEPTB;MUCuOVY6OyEQvF2=MVnTRW5ITVJ?
SK-CO-1MkfXS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?Mlm2TWM2OD1zMD63O|ch|ryPNHXDbohUSU6JRWK=
OAW-28MmLZS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M3XJXmlEPTB;MUCuPVg5QCEQvF2=MlO5V2FPT0WU
HNMX;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MlezTWM2OD1zMT6xNVMyKM7:TR?=MkXCV2FPT0WU
NCI-H1304Mn\hS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MV\JR|UxRTFzLkG1O|Yh|ryPMYXTRW5ITVJ?
DaoyNH31OYxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NEjkRYZKSzVyPUGxMlQ{OzZizszNMVrTRW5ITVJ?
VA-ES-BJM4LrRmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MVnJR|UxRTFzLkexPVUh|ryPM1GxW3NCVkeHUh?=
MCF7NVGzPXZ5T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MkTvTWM2OD1zMT64NVI3KM7:TR?=M2Hwe3NCVkeHUh?=
VM-CUB-1MlrQS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NXHVUFBHUUN3ME2xNU46ODlzIN88US=>M{TnTnNCVkeHUh?=
IPC-298MkfIS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M3rOS2lEPTB;MUGuPVM5OyEQvF2=NUXvXJhbW0GQR1XS
NCI-H2126MofOS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NFHJ[XRKSzVyPUGyMlAzOThizszNM1zkSHNCVkeHUh?=
OVCAR-8M2fybWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M{PxUWlEPTB;MUKuNVE1OSEQvF2=MVrTRW5ITVJ?
SJRH30MXHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Mnr3TWM2OD1zMj6yNlk6KM7:TR?=M3zifXNCVkeHUh?=
DMS-53MnjrS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M3v4TWlEPTB;MUKuNlY1QSEQvF2=MYjTRW5ITVJ?
NCI-H322MMV3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Moq5TWM2OD1zMj6zN|U4KM7:TR?=NEC3S2NUSU6JRWK=
RVH-421MX;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NF;sbFNKSzVyPUGyMlQ6ODRizszNMXTTRW5ITVJ?
RajiNWPZO2dwT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NHr3RXBKSzVyPUGyMlYyPCEQvF2=MUjTRW5ITVJ?
MDA-MB-415MkDCS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?Mke5TWM2OD1zMj62OFQ1KM7:TR?=MX\TRW5ITVJ?
EFE-184M1jSZmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MV7JR|UxRTF{LkexNFYh|ryPNHzKWHNUSU6JRWK=
BFTC-909NHL0enNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NGS1RXNKSzVyPUGyMlkzPDdizszNMYrTRW5ITVJ?
BHYMmnaS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MV7JR|UxRTF|LkOzPUDPxE1?M4jaXHNCVkeHUh?=
YKG-1M2jrbWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MkjkTWM2OD1zMz6zO|Q6KM7:TR?=MYfTRW5ITVJ?
EW-3MV7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M3;Bb2lEPTB;MUOuO|E3OyEQvF2=Mmf1V2FPT0WU
HCC1143NHHvUYFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M3LrPGlEPTB;MUOuO|Q{PyEQvF2=NELUcVBUSU6JRWK=
REHM3Xtdmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NF3sOXFKSzVyPUGzMlg6QDJizszNM{jPVnNCVkeHUh?=
CESSM3PrWmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MUjJR|UxRTF|Lkm0PFkh|ryPMVjTRW5ITVJ?
EFM-19M1;Pdmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M4DxdWlEPTB;MUSuNVEyOiEQvF2=M3LEcnNCVkeHUh?=
U031NG\JVGRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Mn\jTWM2OD1zND60NFg2KM7:TR?=NGK4PVRUSU6JRWK=
ES1NVrXTIxnT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M3rIOGlEPTB;MUSuOFg2OSEQvF2=MXzTRW5ITVJ?
HSC-3MX7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M3PtfWlEPTB;MUSuOlIyPSEQvF2=NEfIbGRUSU6JRWK=
LOXIMVINYXpOYY3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NWf4O4tvUUN3ME2xOE44ODZ6IN88US=>NXnjXo9XW0GQR1XS
A388NWLndoVTT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NWHNZnFwUUN3ME2xOE44PTV4IN88US=>M{jBTXNCVkeHUh?=
KP-N-YSM1[4Vmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MlHQTWM2OD1zND63O|Mh|ryPMUXTRW5ITVJ?
Capan-2M3\0T2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MkDDTWM2OD1zND63PFYh|ryPNH;KOYxUSU6JRWK=
SKG-IIIaM4n6RWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NWPLR5hnUUN3ME2xOE45QDZ{IN88US=>M1LFfnNCVkeHUh?=
HELMVvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M2jPdmlEPTB;MUSuPFk6PyEQvF2=NHHFXopUSU6JRWK=
BENMYjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MYjJR|UxRTF2Lkm3OlYh|ryPNFLmO2VUSU6JRWK=
MC116MVvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NV;vVGZTUUN3ME2xOU4yPTl7IN88US=>MXjTRW5ITVJ?
IGROV-1MX3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M2XWUWlEPTB;MUWuNlMyPyEQvF2=NGPmOWhUSU6JRWK=
NCI-H1648NGOx[GlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NHLVXXZKSzVyPUG1MlU{ODVizszNM2DXWXNCVkeHUh?=
ABC-1NYj0RXZbT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=Mm\LTWM2OD1zNT64NFM{KM7:TR?=NXrPbnZNW0GQR1XS
EW-18MWrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NHTEOXdKSzVyPUG1Mlk6PzlizszNMYHTRW5ITVJ?
BC-3NV\yRpF1T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MYXJR|UxRTF4LkC1OlIh|ryPM2rYO3NCVkeHUh?=
NCI-H1437MmPVS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MWTJR|UxRTF4LkC2Olch|ryPMYjTRW5ITVJ?
SCC-15M3z3c2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7M3;XV2lEPTB;MU[uNlgzPSEQvF2=NVvlc4c6W0GQR1XS
TTM1HJPWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NFK5XYpKSzVyPUG2MlU5QDhizszNM2nNeXNCVkeHUh?=
KINGS-1NHnDfYVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MmDsTWM2OD1zNj64Nlc{KM7:TR?=NUnmTmhGW0GQR1XS
C32M37IN2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MU\JR|UxRTF4Lkm3NVch|ryPMoDuV2FPT0WU
SBC-5NVzOVG4xT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=Mn;ETWM2OD1zNz6xOFc6KM7:TR?=M1j2OnNCVkeHUh?=
NB1NVzKR217T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NWDuVnZLUUN3ME2xO{4{OTh6IN88US=>MWTTRW5ITVJ?
EB-3Mo[0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M4TE[WlEPTB;MUeuOVc3KM7:TR?=MmPlV2FPT0WU
NCI-H748MVnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NXPzUmZFUUN3ME2xO{44ODN3IN88US=>NYXUfno1W0GQR1XS
IST-SL1NXHrblhbT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MU\JR|UxRTF5Lke1NlYh|ryPNEDsdmFUSU6JRWK=
WM-115NH;PWmJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NE\YfXpKSzVyPUG3MlgxQDVizszNMX;TRW5ITVJ?
NCI-H226NYHKZWdMT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MYHJR|UxRTF5Lkm1OFYh|ryPMkfuV2FPT0WU
CAL-33NXy1cnVuT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MoS3TWM2OD1zOD6yO|gyKM7:TR?=M3fvOnNCVkeHUh?=
SCC-4NF\5OHZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M1vGbGlEPTB;MUiuN|IzQSEQvF2=MoC4V2FPT0WU
RMG-IMU\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NVvLU5NbUUN3ME2xPE43QTR5IN88US=>NIfE[WpUSU6JRWK=
KOSC-2Mk\oS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MXnJR|UxRTF6Lke3OFYh|ryPNYnJOndQW0GQR1XS
A2058M4fWRWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MWDJR|UxRTF6LkiyOVUh|ryPNUTKXXV4W0GQR1XS
HCC70NVeyTVN7T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M{Xhd2lEPTB;MUmuN|g6PCEQvF2=MmnZV2FPT0WU
C2BBe1MnzmS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MlfzTWM2OD1zOT60NVQ5KM7:TR?=M1rUSXNCVkeHUh?=
NCI-H650NUjubZlGT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MoXGTWM2OD1zOT61PFk6KM7:TR?=NXuxcmhtW0GQR1XS
CAL-72MVPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MoSzTWM2OD1zOT62O|M4KM7:TR?=NXv6eYNmW0GQR1XS
L-363MXfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NIrnTGxKSzVyPUKwMlAzOTJizszNNH3z[ZBUSU6JRWK=
SNU-423MYfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NULkWI5{UUN3ME2yNE4yODR|IN88US=>Mlv3V2FPT0WU
PLC-PRF-5MUjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NUj6OphzUUN3ME2yNE4{QTB4IN88US=>NVjHT3FGW0GQR1XS
SW1463NHvocGRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Mk\NTWM2OD1{MD60OVI2KM7:TR?=Mo\xV2FPT0WU
769-PNUPUTW1yT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NUS1OYljUUN3ME2yNE43PzZ7IN88US=>M{O3dnNCVkeHUh?=
DMS-79MULHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MlG3TWM2OD1{MD64OFkh|ryPNXr3OohvW0GQR1XS
Saos-2MmTLS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NHvuTJVKSzVyPUKwMlk2PTZizszNMnPUV2FPT0WU
CHP-126NELTWHlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MlzNTWM2OD1{MT60OFYzKM7:TR?=NWOyfHByW0GQR1XS
SW837NVfCNItwT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MkTETWM2OD1{MT60PVM6KM7:TR?=NUCw[pZYW0GQR1XS
SHP-77MYTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NUW1dJl6UUN3ME2yNU43OTJ{IN88US=>NGHnb3VUSU6JRWK=
DBMl7xS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M1LxR2lEPTB;MkGuOlE1OiEQvF2=MYXTRW5ITVJ?
ES5NUn2SZQ3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NEXoTFdKSzVyPUKxMlY5PjRizszNNVrVRY45W0GQR1XS
COR-L23M1\vcGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M4PsZ2lEPTB;MkGuPFA2OSEQvF2=NFfJenBUSU6JRWK=
KU-19-19MlLSS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MWjJR|UxRTJzLki5PFIh|ryPNF\vTJZUSU6JRWK=
T84M1XucWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M{fybmlEPTB;MkGuPVgyQSEQvF2=Mnf6V2FPT0WU
NCI-H630M{\rfmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MX7JR|UxRTJ{LkWzOlMh|ryPMX\TRW5ITVJ?
LU-165NEPZ[lRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M3G3RWlEPTB;MkKuOVU1KM7:TR?=NF\0fY1USU6JRWK=
COLO-792MYrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MX7JR|UxRTJ{LkexNVEh|ryPNGHMdZhUSU6JRWK=
CAL-62Mm\BS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NFnr[oRKSzVyPUKyMlc2OTdizszNMV7TRW5ITVJ?
HCE-TNHL4NnJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MX;JR|UxRTJ{Lki2NFYh|ryPNGnI[JFUSU6JRWK=
BB65-RCCMX;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NWf3TohSUUN3ME2yN{4xOzR2IN88US=>NYXMc3N7W0GQR1XS
SiHaNG\wSVhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NYfuVpJrUUN3ME2yN{4{QTZ6IN88US=>MWXTRW5ITVJ?
NCI-H2081MYXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NYjCcmJiUUN3ME2yOE4xPjRzIN88US=>M{Trc3NCVkeHUh?=
U251Mm\3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NGXNfItKSzVyPUK0MlA3PjhizszNNXLQNlRKW0GQR1XS
LoVoMUHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M4nYTGlEPTB;MkSuPVI5OiEQvF2=Mm[3V2FPT0WU
GCIYMVjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NVrjXpN2UUN3ME2yOU4zQDd5IN88US=>MVLTRW5ITVJ?
NUGC-3NGXYR3lIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NYnueVZXUUN3ME2yOU4{OzF4IN88US=>NIDhO4FUSU6JRWK=
LNCaP-Clone-FGCMonIS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NYPMNpNoUUN3ME2yOU4{PDl6IN88US=>MXPTRW5ITVJ?
PA-1MYrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NWDqe4pWUUN3ME2yOU43QDN|IN88US=>MmmxV2FPT0WU
OE33M4\HbGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MlS1TWM2OD1{NT62PFU{KM7:TR?=NXiwfIVXW0GQR1XS
HT-29M3\zN2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NF\o[GJKSzVyPUK1Mlc5PzlizszNNWPQN2F6W0GQR1XS
RCM-1NEO2fY1Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M3vnR2lEPTB;MkWuPVY2PiEQvF2=NHnQXWxUSU6JRWK=
NCI-H1522NVvhO5c{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MmWwTWM2OD1{NT65PVEyKM7:TR?=MmTuV2FPT0WU
LB373-MEL-DNY\Od2VbT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M2ftW2lEPTB;Mk[uNVcxQCEQvF2=NHG4dY9USU6JRWK=
NCI-H1436NFvadG5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MUfJR|UxRTJ4LkK3N|gh|ryPNXnLfGxvW0GQR1XS
COLO-824NXjjNVQ{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M3HvS2lEPTB;Mk[uOFAxOiEQvF2=NWSyVWQ6W0GQR1XS
CP50-MEL-BMUnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MUXJR|UxRTJ4LkW2O|Uh|ryPMkXxV2FPT0WU
EGI-1NXHlNG9oT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MnLPTWM2OD1{Nz6yOlk5KM7:TR?=MnnXV2FPT0WU
LAN-6MoDZS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M2CxbGlEPTB;MkeuN|U6QCEQvF2=M{O5N3NCVkeHUh?=
GAKM4TKc2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7Mn\sTWM2OD1{Nz60NlI2KM7:TR?=M{Dpd3NCVkeHUh?=
MDA-MB-175-VIIM3jVVmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NEP1eVNKSzVyPUK3MlUxPTNizszNNHq1RoJUSU6JRWK=
JVM-2NX7Cdm8{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NWDKZVd6UUN3ME2yO{43PjJ{IN88US=>NV\BUVY2W0GQR1XS
UACC-257NYTxVJF{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MkTvTWM2OD1{Nz62PFc5KM7:TR?=MWjTRW5ITVJ?
SW1783M2[ye2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NFnGdJRKSzVyPUK3Mlc4QDNizszNNGnMVnpUSU6JRWK=
HT-3NIfrRXZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NFK5VmlKSzVyPUK4MlIyPjZizszNNYTtO41WW0GQR1XS
RLMkjzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NHjodGJKSzVyPUK4MlU6OTFizszNNGrrW|VUSU6JRWK=
TK10M{K3Wmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7Mn\kTWM2OD1{OD62OVM2KM7:TR?=MlLtV2FPT0WU
HT55MoTRS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NHHxPW5KSzVyPUK5MlA2PjVizszNMoW5V2FPT0WU
BT-20Mnr4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MYfJR|UxRTJ7LkC1PFYh|ryPNUWwR3BMW0GQR1XS
TGBC24TKBMkLVS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NGTUfGNKSzVyPUK5MlE5OzFizszNNYjOWYc6W0GQR1XS
HSC-2NEi4PFlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M3TuRWlEPTB;MkmuN|AxOSEQvF2=MVXTRW5ITVJ?
COLO-205M4r6fGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M4noe2lEPTB;MkmuN|k1PCEQvF2=M{LFSHNCVkeHUh?=
GT3TKBM1H3[mdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NHL0flBKSzVyPUK5MlY5PzdizszNNHnESXZUSU6JRWK=
T47DMn36S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MYHJR|UxRTJ7Lki1PFIh|ryPMUTTRW5ITVJ?
OMC-1MVjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M{W2NWlEPTB;M{CuNVkyQSEQvF2=MWrTRW5ITVJ?
PFSK-1NX;scm1tT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MYrJR|UxRTNzLkK2OVkh|ryPNUDRPWI4W0GQR1XS
JEG-3M2j5PGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MYTJR|UxRTNzLkO1OlEh|ryPMkjUV2FPT0WU
RDM1H2b2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7M4TGdWlEPTB;M{GuOVEyPSEQvF2=MmDlV2FPT0WU
NCI-H64NFmwV3RIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M4W0emlEPTB;M{KuOFE4QSEQvF2=MXTTRW5ITVJ?
DMS-114NIn5PWhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M4jZXmlEPTB;M{KuOFE5OiEQvF2=M2D3VHNCVkeHUh?=
NCI-H661Mkn0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M3nHd2lEPTB;M{KuOlUxOSEQvF2=MnHkV2FPT0WU
CAL-148MX;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Ml7PTWM2OD1|Mj62OlY2KM7:TR?=MXPTRW5ITVJ?
HuP-T3NHny[ZdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M2TXWGlEPTB;M{KuPVM{QCEQvF2=MUnTRW5ITVJ?
ES4NYrkXJBPT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MmXCTWM2OD1|Mz6xO|A2KM7:TR?=NFe3PWFUSU6JRWK=
Ca9-22NXzzfoh6T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MV7JR|UxRTN|LkS2NFEh|ryPMofhV2FPT0WU
LP-1MkD3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MoPtTWM2OD1|ND6wPUDPxE1?Mkj3V2FPT0WU
AU565NHj6ZnJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NIe3bHdKSzVyPUO0MlUxPjlizszNNEjueFBUSU6JRWK=
MDA-MB-453MkDuS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MnPkTWM2OD1|NT6xOFI3KM7:TR?=M1;yc3NCVkeHUh?=
SNU-C1NID0OJhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Mkj2TWM2OD1|NT6xO|Eh|ryPMkjsV2FPT0WU
SW13MWDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NW\M[FZ2UUN3ME2zOU41ODd4IN88US=>MYfTRW5ITVJ?
NCI-H2122M2\wd2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NUjTSVVoUUN3ME2zOU42PTl6IN88US=>NXXvTXJiW0GQR1XS
NCI-H1395M{S0Zmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M2Hhd2lEPTB;M{WuOlY6OSEQvF2=NWrZRpV4W0GQR1XS
J-RT3-T3-5NXT2dGtRT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MUjJR|UxRTN4LkCyPVQh|ryPM3XEdnNCVkeHUh?=
COR-L279M1O0NWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NIjqdnhKSzVyPUO2MlE6QDFizszNMkTnV2FPT0WU
ATN-1M3T1S2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7M4rVXmlEPTB;M{[uPFUyPiEQvF2=MUjTRW5ITVJ?
HCC2998MX\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MVLJR|UxRTN4Lki1O|Eh|ryPNXi1TIRGW0GQR1XS
UM-UC-3MWHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NFKzS3lKSzVyPUO2Mlg3PzVizszNNGLsW2ZUSU6JRWK=
DV-90NU\oZphHT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MWLJR|UxRTN4LkmwOlch|ryPNVjveZJLW0GQR1XS
ES8NF;aWWxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MmnwTWM2OD1|Nj65N|E5KM7:TR?=M1r5THNCVkeHUh?=
YAPCNH;rdm5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M13MPWlEPTB;M{[uPVY2PCEQvF2=M2DCV3NCVkeHUh?=
HCC1599MVzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NWXQW5RDUUN3ME2zO{4yPjF6IN88US=>MmrJV2FPT0WU
UMC-11NXPaWHFYT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NUSzZpdkUUN3ME2zO{4zPTB|IN88US=>MkLuV2FPT0WU
THP-1NYHNXZhiT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M3HPXGlEPTB;M{euNlg3QCEQvF2=MWjTRW5ITVJ?
OCUB-MNEX0b2tIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M4\jfWlEPTB;M{euNlg6OSEQvF2=M4H4cnNCVkeHUh?=
NCI-H1693NV;oTpo2T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MXjJR|UxRTN5LkOyN|Mh|ryPNYT2cohkW0GQR1XS
NCI-H345NI\EU4VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NHT5W|lKSzVyPUO3MlM3OjRizszNMWLTRW5ITVJ?
COLO-800NUjhS21lT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MmDLTWM2OD1|Nz61Olch|ryPMkTEV2FPT0WU
COLO-320-HSRMkizS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M3jlTmlEPTB;M{iuN|Q6OiEQvF2=M2X3[XNCVkeHUh?=
NCI-H596NIfLPVVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MmL4TWM2OD1|OD60OFg6KM7:TR?=MoTYV2FPT0WU
NCI-H187MofQS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M4nFXGlEPTB;M{iuO|M1PCEQvF2=MV\TRW5ITVJ?
ECC4NILJbm9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NGK2OHdKSzVyPUO5MlA5OTRizszNNVnTbJNMW0GQR1XS
KP-4M3:0NWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7Ml7oTWM2OD1|OT6xNlM2KM7:TR?=M4ruTXNCVkeHUh?=
NCI-H2227M4DK[2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MY\JR|UxRTN7LkO5OFkh|ryPMmPrV2FPT0WU
22RV1MknZS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MmHtTWM2OD1|OT64N|k5KM7:TR?=NXjwWVN6W0GQR1XS
SASMmH0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NGXWdndKSzVyPUSwMlA6PiEQvF2=M13QN3NCVkeHUh?=
PANC-10-05Mlf3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NVTEXWNQUUN3ME20NE4yQDJ6IN88US=>M4LXWHNCVkeHUh?=
MDA-MB-468M4LteWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NHrYcG1KSzVyPUSwMlU{PDZizszNMn\yV2FPT0WU
RPMI-7951MX\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M1W3S2lEPTB;NEGuNlA4PSEQvF2=Mn;PV2FPT0WU
BB49-HNCMWjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M3jiTWlEPTB;NEGuNlE4QSEQvF2=MXHTRW5ITVJ?
23132-87NVzFS3NOT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NV\0V|czUUN3ME20NU4zPzN{IN88US=>NV;3bWhpW0GQR1XS
HCC1569MnjlS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MkXjTWM2OD12MT6yPFg2KM7:TR?=M2Had3NCVkeHUh?=
CP66-MELM13NcWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NHPLcHJKSzVyPUSyMlE5QDZizszNMoT6V2FPT0WU
K-562M{nCdWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MXTJR|UxRTR{LkK4OVQh|ryPNH\5dJpUSU6JRWK=
OCI-AML2NE\uRZdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M{jwXGlEPTB;NEKuPFk4PCEQvF2=NYK5WlQ1W0GQR1XS
SW756M2i2ZWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M1mxN2lEPTB;NEOuNFM5QCEQvF2=M2e2V3NCVkeHUh?=
M14NUfrSZZkT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M{TDSWlEPTB;NEOuN|E5QSEQvF2=M3f0SnNCVkeHUh?=
NCI-H1623Ml7PS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NGHZc3dKSzVyPUSzMlQ3PCEQvF2=M3HPUnNCVkeHUh?=
KNS-81-FDMn3US5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NWfEcI04UUN3ME20N{44PjJizszNNVrD[W5TW0GQR1XS
TGBC1TKBNFLtToJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NUjuWpJjUUN3ME20N{46ODl7IN88US=>Mn75V2FPT0WU
RERF-LC-MSMUjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NGTESVVKSzVyPUSzMlkzQDFizszNNUHRRY9xW0GQR1XS
PC-3NV7mRZdRT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NGmzOGpKSzVyPUS0MlQ{PDdizszNNHnRcHRUSU6JRWK=
HuP-T4MWTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M4TQO2lEPTB;NESuOFQ4PCEQvF2=M4XzS3NCVkeHUh?=
NCI-H510AM2rhOWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MXrJR|UxRTR2LkewPEDPxE1?NEGyeJNUSU6JRWK=
LB2518-MELNXTVNHVsT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NH74PI9KSzVyPUS0Mlc6OzdizszNNEXoeI9USU6JRWK=
TE-5NILONIpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MmroTWM2OD12NT65OVgyKM7:TR?=NUHvRmY4W0GQR1XS
EW-24NU\4OoFJT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NF24[odKSzVyPUS2MlE4OjNizszNNEH0S2hUSU6JRWK=
LB647-SCLCMoeyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M{P5WGlEPTB;NE[uNlE2PSEQvF2=NIXicllUSU6JRWK=
NCI-H524M4TLSWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NH:4eHpKSzVyPUS2MlcyQDVizszNNHP5TFVUSU6JRWK=
EW-11NYrhbWx2T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NIfUeoxKSzVyPUS2Mlk{PzNizszNNVvpXWJ7W0GQR1XS
KALS-1NHq1eHhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M1nGemlEPTB;NEeuNlA3PiEQvF2=M3e2V3NCVkeHUh?=
BT-474NH;jemZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MoPwTWM2OD12Nz60NlE3KM7:TR?=NXXkUmZyW0GQR1XS
SK-N-ASM1jGXmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MmrSTWM2OD12Nz64PFgh|ryPMn\SV2FPT0WU
HCC2157MnzyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NETIVHNKSzVyPUS4MlA4PiEQvF2=NHroXnVUSU6JRWK=
HCC1954MlfBS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NEDh[XVKSzVyPUS4MlE4ODRizszNNUTwc4RYW0GQR1XS
FADUMVjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MW\JR|UxRTR6LkOwN|Eh|ryPMWrTRW5ITVJ?
S-117MXfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M{nDUWlEPTB;NEiuN|gyPSEQvF2=MXTTRW5ITVJ?
LS-1034MULHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M37uWGlEPTB;NEiuO|A3PyEQvF2=NXf2d286W0GQR1XS
CAMA-1M2HDV2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MnL1TWM2OD12OT61OVQ{KM7:TR?=MXjTRW5ITVJ?
LU-134-AMmG4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?Mn\uTWM2OD12OT64NFg2KM7:TR?=M4jyOnNCVkeHUh?=
NCI-H1838MVjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NVPiT2pLUUN3ME20PU45ODh5IN88US=>NYrmbVdmW0GQR1XS

... Click to View More Cell Line Experimental Data

In vivo In a mouse xenograft model of Ba/F3 cells expressing native Bcr-Abl, AP24534 (2.5 mg/kg and 5 mg/kg) prolongs mice median survival. In the xenograft model of Ba/F3 Bcr-AblT315I, AP24534 (10 mg/kg–50 mg/kg) significantly suppresses tumor growth. AP24534 (30 mg/kg) decreases the phosphorylated Bcr-Abl and phosphorylated CrkL levels in the tumors. [2]
Features

Protocol(Only for Reference)

Kinase Assay: [1]

Peptide substrate phosphorylation assays with GST-Abl kinase domains The effect of AP24534 (0-320 nM) on GST-Abl kinase activity is assessed by using a synthetic peptide substrate (Abltide: EAIYAAPFAKKK). Assays are carried out at 30 °C for 15 min in 25 μL reaction mixture: 8 mM MOPS (pH 7), 0.2 mM EDTA, 50 μM Abltide, 30 mM MgCl2, 10 mM β-glycerol phosphate, 1 mM EGTA, 0.002% Brij-35, 0.4 mM DTT, 0.2 mg/mL BSA, 0.4 mM sodium orthovanadate, 10 nM WT or mutant GST-Abl kinase, and 100 µM ATP/γ-32[P]ATP (5000 cpm/pmol). Reactions are terminated by transferring a portion of the reaction mixture onto a p81 phosphocellulose filter and immersing in 0.75% phosphoric acid. Filters are washed 3 times in 0.75% phosphoric acid, rinsed in acetone, and air dried; phosphate incorporation is determined by scintillation counting. All results are corrected for background binding to the filters, as determined by omitting peptide substrate from the kinase reaction. Time course experiments to establish the linear range of enzymatic activity precedes kinase assays.

Cell Assay: [2]

Cell lines Ba/F3 cells expressing Bcr-Abl or a range of single mutations in the kinase domain of Bcr-Abl
Concentrations 0-625 nM
Incubation Time 72 hours
Method Ba/F3 cell lines are distributed in 96-well plates (4 × 103 cells/well) and incubated with AP24534 for 72 hours. Proliferation is measured using a methanethiosulfonate (MTS)-based viability assay (CellTiter96 Aqueous One Solution). All values are normalized to the control wells with no drug. IC50 values are reported as the mean of three independent experiments performed in quadruplicat

Animal Study: [1]

Animal Models Mouse xenograft models of Ba/F3 cells expressing Bcr-Abl or Bcr-AblT315I
Formulation Dissolved in 25 mM citrate buffer, pH 2.75
Dosages 2.5 mg/kg and 5 mg/kg for Ba/F3 Bcr-Abl; 2.5 mg/kg–50 mg/kg for Ba/F3 Bcr-AblT315I
Administration Oral gavage once daily

Conversion of different model animals based on BSA (Value based on data from FDA Draft Guidelines)

SpeciesMouseRatRabbitGuinea pigHamsterDog
Weight (kg)0.020.151.80.40.0810
Body Surface Area (m2)0.0070.0250.150.050.020.5
Km factor36128520
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of resveratrol used for a mouse (22.4 mg/kg) to a dose based on the BSA for a rat, multiply 22.4 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for resveratrol of 11.2 mg/kg.

Rat dose (mg/kg) = mouse dose (22.4 mg/kg) ×  mouse Km(3)  = 11.2 mg/kg
rat Km(6)
1

References

[1] O'Hare T, et al. Cancer Cell, 2009, 16(5), 401-412.

[2] Huang WS, et al. J Med Chem, 2010, 53(12), 4701-4719.

view more

Clinical Trial Information( data from http://clinicaltrials.gov, updated on 2016-07-30)

NCT Number Recruitment Conditions Sponsor
/Collaborators
Start Date Phases
NCT02829840 Not yet recruiting Leukemia|FLT3-Mutated Acute Myeloid Leukemia|FLT3-Mutated High-Risk Myelodysplastic Syndrome M.D. Anderson Cancer Center|Ariad Pharmaceuticals September 2016 Phase 1|Phase 2
NCT02776605 Not yet recruiting ALL PETHEMA Foundation June 2016 Phase 2
NCT01888562 Withdrawn Endometrial Neoplasms Washington University School of Medicine January 2016 --
NCT02627677 Recruiting Chronic Phase Chronic Myeloid Leukemia Ariad Pharmaceuticals December 2015 Phase 3
NCT02398825 Not yet recruiting Chronic Myeloid Leukemia|Chronic Phase|Adults Gruppo Italiano Malattie EMatologiche dellAdulto December 2015 Phase 2

view more

Chemical Information

Download Ponatinib (AP24534) SDF
Molecular Weight (MW) 532.56
Formula

C29H27F3N6O

CAS No. 943319-70-8
Storage 3 years -20℃powder
2 years -80℃in solvent
Synonyms N/A
Solubility (25°C) * In vitro DMSO 30 mg/mL (56.33 mM)
Water <1 mg/mL
Ethanol <1 mg/mL
In vivo 30% PEG400+0.5% Tween80+5% propylene glycol 10 mg/mL
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.
Chemical Name 3-(2-(imidazo[1,2-b]pyridazin-3-yl)ethynyl)-4-methyl-N-(4-((4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)benzamide

Frequently Asked Questions

  • Question 1
    Is the pre-solubilized inhibitor suitable for in vivo whole animal studies? Whether the solvent contains any non-DMSO stabilizer?

    Answer: Our 10mM Ponatinib in DMSO solution is in pure DMSO and there is not other stabilizer added. You can use it for animal study. The vehicle we suggest for Ponatinib is: 30% PEG400/0.5% Tween80/5% Propylene glycol. It is a milky suspension used for oral gavage.

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Related Bcr-Abl Products

  • PX-478 2HCl

    PX-478 2HCl is an orally active, and selective hypoxia-inducible factor-1α (HIF-1α) inhibitor. Phase 1.

  • Defactinib (VS-6063, PF-04554878)

    Defactinib (VS-6063, PF-04554878) is a selective, and orally active FAK inhibitor. Phase 2.

  • SU6656

    SU 6656 is a selective Src family kinase inhibitor with IC50 of 280 nM, 20 nM, 130 nM, and 170 nM for Src, Yes, Lyn, and Fyn, respectively.

  • Imatinib Mesylate (STI571)

    Imatinib Mesylate (STI571) is an orally bioavailability mesylate salt of Imatinib, which is a multi-target inhibitor of v-Abl, c-Kit and PDGFR with IC50 of 0.6 μM, 0.1 μM and 0.1 μM in cell-free or cell-based assays, respectively.

  • Nilotinib (AMN-107)

    Nilotinib (AMN-107) is a Bcr-Abl inhibitor with IC50 less than 30 nM in Murine myeloid progenitor cells.

    Features:A selective inhibitor of native and mutant Bcr-Abl.

  • Bafetinib (INNO-406)

    Bafetinib (INNO-406) is a potent and selective dual Bcr-Abl/Lyn inhibitor with IC50 of 5.8 nM/19 nM in cell-free assays, does not inhibit the phosphorylation of the T315I mutant and is less potent to PDGFR and c-Kit. Phase 2.

    Features:Dual Bcr-Abl/Lyn inhibitor.

  • Degrasyn (WP1130)

    Degrasyn (WP1130) is a selective deubiquitinase (DUB: USP5, UCH-L1, USP9x, USP14, and UCH37) inhibitor and also suppresses Bcr/Abl, also a JAK2 transducer (without affecting 20S proteasome) and activator of transcription (STAT).

    Features:WP1130 has an advantage over imatinib mesylate in that its activity is not inhibited by a variety of Abl kinase mutations, including T315I.

  • DCC-2036 (Rebastinib)

    DCC-2036 (Rebastinib) is a conformational control Bcr-Abl inhibitor for Abl1(WT) and Abl1(T315I) with IC50 of 0.8 nM and 4 nM, also inhibits SRC, LYN, FGR, HCK, KDR, FLT3, and Tie-2, and low activity to seen towards c-Kit. Phase 1.

    Features:A conformational control inhibitor of Abl1 and T315I Abl1.

  • GZD824 Dimesylate

    GZD824 Dimesylate is a novel orally bioavailable Bcr-Abl inhibitor for Bcr-Abl(WT) and Bcr-Abl(T315I) with IC50 of 0.34 nM and 0.68 nM, respectively.

  • GNF-2

    GNF-2 is a highly selective non-ATP competitive inhibitor of Bcr-Abl, shows no activity to Flt3-ITD, Tel-PDGFR, TPR-MET and Tel-JAK1 transformed tumor cells.

Recently Viewed Items

Tags: buy Ponatinib (AP24534) | Ponatinib (AP24534) ic50 | Ponatinib (AP24534) price | Ponatinib (AP24534) cost | Ponatinib (AP24534) solubility dmso | Ponatinib (AP24534) purchase | Ponatinib (AP24534) manufacturer | Ponatinib (AP24534) research buy | Ponatinib (AP24534) order | Ponatinib (AP24534) mouse | Ponatinib (AP24534) chemical structure | Ponatinib (AP24534) mw | Ponatinib (AP24534) molecular weight | Ponatinib (AP24534) datasheet | Ponatinib (AP24534) supplier | Ponatinib (AP24534) in vitro | Ponatinib (AP24534) cell line | Ponatinib (AP24534) concentration | Ponatinib (AP24534) nmr
×
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
Contact Us